Welcome to the Waldenstrom’s Macroglobulinemia Foundation of Canada (WMFC)
If you have been diagnosed with Waldenstrom’s Macroglobulinemia (WM) or care for someone who has, welcome to the WMFC family of WM patients, caregivers, friends and relatives. We are a community providing support, research and information on WM.
Sign up for our newsletter below to receive updated information.
**Ensure you receive all the latest news on research, events, the Torch and support by keeping your email up to date and including WMFC and IWMF as trusted senders as well as keeping your mailing address up to date.
Article: 2767 Ibrutinib Is Highly Active As First Line Therapy in Symptomatic Waldenstrom’s MacroglobulinemiaPaper: Ibrutinib Is Highly Active As First Line Therapy in Symptomatic Waldenstrom’s Macroglobulinemia Source: https://ash.confex.com/ash/2017/webprogram/Paper105275.html Program: Oral and Poster Abstracts Session: 623. Mantle Cell, Follicular, and Other IndolentRead More
Article: Primary Endpoints Met in Phase 3 of Imbruvica with Rituximab in Waldenstom’s MacroglobulinemiaDECEMBER 05, 2017 Mathew Shanley Primary Endpoints Met in Phase 3 of Imbruvica with Rituximab in Waldenstom’s Macroglobulinemia A Phase 3 of Imbruvica (ibrutinib) in combination with RituxanRead More